GOSS · Gossamer Bio, Inc.
$0.14
-0.03 (-17.06%)
At close · Jul 20
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company’s existing cash and cash equivalents are not sufficient to fund operating plans for at least one year from the issuance date of these financial statements. Accordingly, these conditions raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$33.09M
Shares
234.70M
Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.
Short Squeeze Score
63/100
Short interest 22.9% of shares — P99
Days to cover 3.2 — P63
Price vs VWAP -27.0% — P12
Short-volume trend -1.5% — P45
Short interest change -4.5% — P33
Worst FTD 0.67% of shares — P91
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
| 2026-06-30 | 53,695,991 | 56,212,006 | -2,516,015 | 3.22 |
| 2026-06-15 | 56,212,006 | 62,815,917 | -6,603,911 | 3.41 |
| 2026-05-29 | 62,815,917 | 40,838,667 | +21,977,250 | 2.84 |
| 2026-05-15 | 40,838,667 | 40,018,309 | +820,358 | 11.48 |
| 2026-04-30 | 40,018,309 | 40,196,107 | -177,798 | 7.65 |
| 2026-04-15 | 40,196,107 | 37,500,300 | +2,695,807 | 4.85 |
| 2026-03-31 | 37,500,300 | 36,622,286 | +878,014 | 2.75 |
| 2026-03-13 | 36,622,286 | 34,715,538 | +1,906,748 | 2.70 |
| 2026-02-27 | 34,715,538 | 31,092,342 | +3,623,196 | 1.00 |
| 2026-02-13 | 31,092,342 | 26,779,236 | +4,313,106 | 5.10 |
| 2026-01-30 | 26,779,236 | 25,222,443 | +1,556,793 | 5.68 |
| 2026-01-15 | 25,222,443 | 24,114,833 | +1,107,610 | 5.43 |
| 2025-12-31 | 24,114,833 | 20,310,911 | +3,803,922 | 4.66 |
| 2025-12-15 | 20,310,911 | 23,438,565 | -3,127,654 | 5.73 |
| 2025-11-28 | 23,438,565 | 24,422,288 | -983,723 | 8.22 |
| 2025-11-14 | 24,422,288 | 24,918,422 | -496,134 | 9.45 |
| 2025-10-31 | 24,918,422 | 26,759,668 | -1,841,246 | 8.01 |
| 2025-10-15 | 26,759,668 | 27,397,216 | -637,548 | 8.24 |
| 2025-09-30 | 27,397,216 | 23,993,214 | +3,404,002 | 6.44 |
| 2025-09-15 | 23,993,214 | 22,046,902 | +1,946,312 | 4.23 |
| 2025-08-29 | 22,046,902 | 20,502,512 | +1,544,390 | 7.14 |
| 2025-08-15 | 20,502,512 | 18,745,165 | +1,757,347 | 6.81 |
| 2025-07-31 | 18,745,165 | 18,122,038 | +623,127 | 5.16 |
Showing 1–23 of 23 settlements
Key facts
CIK
1728117
CUSIP
38341P102
13F (30d)
15 filings
15 filers
Visit website
Investor relations